Chronicling the discovery of interferon tau

Area of Science:

• Reproductive biology
• Endocrinology
• Immunology

Background:

• Interferon tau (IFNT), discovered 38 years ago in ovine conceptus cultures, was initially recognized for its antiluteolytic function.
• Native and recombinant IFNT exhibit antiviral, antiproliferative, and immunomodulatory activities.
• IFNT and progesterone cooperatively regulate interferon-stimulated genes in ovine uterine epithelia.

Observation:

• IFNT signaling, independent of STAT1/STAT2, promotes genes essential for conceptus growth, such as nutrient transporters.
• IFNT plays a role in a complex mechanism involving placental lactogen and placental growth hormone, influencing uterine gland development and gene expression throughout gestation.
• Systemic IFNT induces interferon-stimulated genes that modulate progesterone secretion by the corpus luteum.

Findings:

• IFNT's unique antiluteolytic activity prevents corpus luteum regression in nonpregnant ewes.
• IFNT signaling pathways are crucial for conceptus development and uterine function.
• IFNT demonstrates potential therapeutic applications owing to its anti-inflammatory properties and low cytotoxicity.

Implications:

• IFNT's multifaceted roles highlight its importance in reproductive physiology and conceptus survival.
• Understanding IFNT's signaling mechanisms can provide insights into developmental biology and endocrine regulation.
• IFNT's therapeutic potential warrants further investigation for treating metabolic and autoimmune diseases.